Fund managers believe the ability to finance and refinance deals on attractive terms, as well as a wider array of paths to liquidity, will underpin performance in Asia
Asian private equity’s not-so-dirty little secret is that large-cap buyout managers have revised their underwriting from returns of 25%-plus to around 20% in recent years – a result of increased competition...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.